Clofazimine for(in CF) NTM (CLAM320B2002M )

I'm Interested!

Multiple Patient Program for Lamprene (clofazimine) for the treatment of Non-Tuberculous Mycobacterial (NTM) Infections

Sex at Birth: Any
Age: Adult (18 - 64), Older Adult (65+)
Accepting Healthy People: No
Type: Compassionate Use
Trial Phase: NA
Conditions Being Studied: Cystic Fibrosis (CF)

Study Purpose

Lamprene®/Clofazimine is approved by the United States Food and Drug Administration (FDA) for the treatment of another condition called leprosy. It is being tested in non-Novartis clinical studies for drug resistant tuberculosis and non-tuberculous mycobacteria (NTM), which includes Mycobacterium abscessus.

Who Can Participate

Age: 18 and older

Principal Investigator
Alex Gifford MD

Department/Division
Pulmonology (Pediatrics)

Locations

UH Cleveland Medical Center
11100 Euclid Avenue
Cleveland OH, 44106

Get Directions

UH IRB: STUDY20211505
StudyID: 2021-0828
ClinicalTrials.gov: N/A

I'm Interested!

Fill out our online form

Questions or concerns? We're here to help.

Non-cancer Trials: 1-833-78TRIAL or Contact Us Online

Cancer Trials: 1-800-641-2422